We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
Cap. Flow
-$179M
Cap. Flow %
-0.34%
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$67.7M
2
CTVA icon
Corteva
CTVA
+$33.4M
3
TCF
TCF Financial Corporation Common Stock
TCF
+$19.3M
4
SPOT icon
Spotify
SPOT
+$15.3M
5
AMCR icon
Amcor
AMCR
+$15M

Sector Composition

Rank Sector Weight
1 Technology 18.25%
2 Financials 15.55%
3 Healthcare 13.39%
4 Consumer Discretionary 10.43%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGG icon
1076
Chegg
CHGG
$110M
$6.21M 0.01%
160,953
+15,030
+10% +$566K
ROIC
1077
DELISTED
Retail Opportunity Investments Corp.
ROIC
$6.2M 0.01%
361,740
+9,674
+3% +$168K
CUB
1078
DELISTED
Cubic Corporation
CUB
$6.2M 0.01%
96,098
+6,004
+7% +$353K
HEI icon
1079
HEICO Corp
HEI
$49.8B
$6.19M 0.01%
46,252
-5,953
-11% -$662K
SHO icon
1080
Sunstone Hotel Investors
SHO
$2.19B
$6.19M 0.01%
451,425
+15,854
+4% +$224K
SCL icon
1081
Stepan Co
SCL
$1.46B
$6.18M 0.01%
67,237
+1,399
+2% +$125K
CACC icon
1082
Credit Acceptance
CACC
$5.95B
$6.17M 0.01%
12,754
-972
-7% -$462K
NEO icon
1083
NeoGenomics
NEO
$1.96B
$6.16M 0.01%
280,714
+31,116
+12% +$683K
ITRI icon
1084
Itron
ITRI
$4.36B
$6.15M 0.01%
98,295
+2,941
+3% +$163K
MYGN icon
1085
Myriad Genetics
MYGN
$270M
$6.14M 0.01%
221,004
+16,115
+8% +$455K
DLX icon
1086
Deluxe
DLX
$1.18B
$6.14M 0.01%
150,908
+3,104
+2% +$131K
AN icon
1087
AutoNation
AN
$7.11B
$6.13M 0.01%
146,263
-722
-0.5% -$28.7K
ENR icon
1088
Energizer
ENR
$1.44B
$6.13M 0.01%
158,533
-7,550
-5% -$338K
USFD icon
1089
US Foods
USFD
$22.2B
$6.12M 0.01%
171,250
-406
-0.2% -$14.7K
KDP icon
1090
Keurig Dr Pepper
KDP
$42.3B
$6.11M 0.01%
211,428
+26,402
+14% +$752K
MDRX
1091
DELISTED
Veradigm Inc. Common Stock
MDRX
$6.09M 0.01%
523,558
-11,812
-2% -$120K
PTEN icon
1092
Patterson-UTI
PTEN
$3.98B
$6.08M 0.01%
528,645
-20,509
-4% -$264K
RH icon
1093
RH
RH
$3.13B
$6.02M 0.01%
52,107
-753
-1% -$77.7K
GNW icon
1094
Genworth Financial
GNW
$3.76B
$6.02M 0.01%
1,622,503
+44,487
+3% +$158K
RBC icon
1095
RBC Bearings
RBC
$17.4B
$6.02M 0.01%
36,076
+1,255
+4% +$178K
G icon
1096
Genpact
G
$5.96B
$6.02M 0.01%
157,975
-6,405
-4% -$233K
PRGS icon
1097
Progress Software
PRGS
$1.66B
$6.01M 0.01%
137,739
+3,926
+3% +$170K
PLNT icon
1098
Planet Fitness
PLNT
$4.42B
$5.99M 0.01%
82,693
-33,882
-29% -$2.55M
BERY
1099
DELISTED
Berry Global Group, Inc.
BERY
$5.96M 0.01%
123,331
-5,305
-4% -$256K
BLUE
1100
DELISTED
bluebird bio
BLUE
$5.95M 0.01%
3,613
-580
-14% -$1M

Similar funds

RhumbLine Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
  • RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
  • RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
  • RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
  • RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
  • RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.